Oxford vaccine produces immune response

 

WHAT YOU NEED TO KNOW ABOUT THE CORONAVIRUS TODAY Oxford vaccine produces immune response The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in older and younger adults, and adverse responses were lower among the elderly, British drug maker AstraZeneca said on Monday. A vaccine is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world. COVID-19 infections are still rising in 78 countries. Track daily COVID-19 infections and deaths data for 240 countries and territories around the world. Europe sees difficult months ahead European leaders warned of difficult months ahead as a string of countries reported record increases in COVID-19 cases. France posted more than 50,000 daily cases for the first time on Sunday, while the continent passed 250,000 deaths. Governments have been desperate to avoid the lockdowns which curbed the disease at the start of the year at the cost of shutting down entire economies. But the steady rise in new cases has forced them to ratchet up controls steadily. Despite deaths, South Korea urges flu vaccinations South Korea urged citizens to get vaccinated against influenza and reduce the chances of an outbreak that coincides with the battle against the coronavirus, as it began free inoculations for the last eligible group. Public anxiety over the safety of flu vaccines has surged after at least 48 people died this month following vaccinations. Authorities have said they found no direct link between the deaths and the flu shots and have sought to reassure South Koreans about the safety of the vaccines against flu. Pandemic gives African money transfer firms a boost Africa-focused money transfer companies are seeing a boom, despite predictions from the World Bank of a historic 20% drop to $445 billion in remittances to poorer countries this year due to a pandemic-induced global economic slump. Many migrant workers are turning to digital transfer services, often for the first time, to send money back home to African countries, according to executives in the mobile financial services industry. From Breakingviews - Corona Capital: W-shaped recovery, UK investors. New lockdowns in Italy and Spain cast fresh doubt over Europe’s economic rebound; And a startup catering to UK retail investors, PrimaryBid, gets an endorsement from the London Stock Exchange. Catch up with the latest financial insights. Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic. We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources. Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages? We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.

WHAT YOU NEED TO KNOW ABOUT THE CORONAVIRUS TODAY

WHAT YOU NEED TO KNOW ABOUT THE CORONAVIRUS TODAY WHO study casts doubt on remdesivir’s benefits Gilead Sciences has questioned the findings of a World Health Organization (WHO) study which concluded that its COVID-19 drug remdesivir does not help patients who have been admitted to hospital. The American company told Reuters the data appeared inconsistent, the findings were premature and that other studies had validated the drug’s benefits. In a blow to one of the few drugs being used to treat people with COVID-19, the WHO said its “Solidarity” trial had concluded that remdesivir appeared to have little or no effect on 28-day mortality or length of hospital stays among patients with the respiratory disease. U.S. cases surpass 8 million U.S. coronavirus cases crossed 8 million on Thursday, rising by 1 million in less than a month, as another surge hits the nation hard at the onset of cooler weather. The United States reported 60,000 new infections on Wednesday, the highest daily increase since Aug. 14, with rising cases in every region, especially the Midwest. According to a Reuters analysis, 25 states have so far set records for increases in new cases in October. Source Reuters